UNITEDHEALTH GROUP INC Chief Accounting Officer Dennis Andrew Stankiewicz reported an acquisition of common stock tied to existing equity awards. On March 17, 2026, he received 68.058 shares of common stock at no cost as dividend equivalents on outstanding restricted stock units, which are subject to the same vesting conditions and are forfeited if the underlying units do not vest. Following this award, his directly held common stock position increased to 10,205.939 shares, indicating a routine compensation-related update rather than an open-market trade.
UnitedHealth Group director Paul R. Garcia received an equity-based award linked to existing deferred stock units. On March 17, 2026, he acquired 16 shares of common stock at $0.00 per share, described as dividend equivalents paid on vested deferred stock units that are immediately vested and subject to the same terms as the underlying units.
Following this grant, Garcia directly holds 3,330 shares of UnitedHealth Group common stock. He also has indirect holdings reported through a revocable trust and additional trusts, reflecting shares held in estate-planning vehicles rather than through open‑market transactions.
UNITEDHEALTH GROUP INC director John H. Noseworthy received 52 shares of common stock as a grant tied to dividend equivalents on vested deferred stock units. The shares were acquired at no cost, are immediately vested, and follow the same terms as the underlying deferred stock units. After this award, he directly holds 7,049 shares of common stock.
UNITEDHEALTH GROUP INC executive Christopher R. Zaetta received additional common stock linked to existing equity awards. On March 17, 2026, he acquired 89.629 shares of Common Stock at a stated price of $0.00 per share, reported as a grant or award acquisition.
The footnote explains this represents dividend equivalents paid on outstanding restricted stock units. These dividend equivalents follow the same vesting terms as the underlying restricted stock units and will be forfeited if those units do not vest. After this transaction, Zaetta directly holds 16,716.169 shares of Common Stock.
UNITEDHEALTH GROUP INC executive Timothy John Noel, Chief Executive Officer of UnitedHealthcare, received an acquisition of 102.329 shares of common stock as of March 17, 2026. These shares represent dividend equivalents on outstanding restricted stock units and are granted at no cash cost to him.
After this award, his directly held common stock position reported in this filing increased to 17,574.653 shares. The dividend equivalents are subject to the same vesting conditions as the underlying restricted stock units and will be forfeited if those units do not vest, making this a routine, compensation-related equity accrual rather than an open‑market purchase.
UNITEDHEALTH GROUP INC director Frederick William McNabb III reported an automatic share-based compensation event. He acquired 64 shares of common stock on March 17, 2026 with a reported price of $0.0000 per share, described as dividend equivalents on vested deferred stock units. These dividend equivalents are immediately vested and follow the same terms as the underlying deferred stock units. After this credit, his directly held common stock position increased to 14,774 shares, reflecting a small, routine adjustment rather than an open-market purchase.
UnitedHealth Group director Timothy Patrick Flynn reported a small stock award tied to existing deferred compensation. On March 17, 2026, he acquired 79 shares of UnitedHealth common stock at $0.0000 per share as dividend equivalents on vested deferred stock units, which are immediately vested and follow the same terms as the underlying units. Following this grant, his direct holdings total 10,239 shares of common stock, and he also holds 6,033 shares indirectly through a trust.
HEMSLEY STEPHEN J reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC director and CEO Stephen J. Hemsley received an award of 61 shares of common stock on March 17, 2026. This was reported as a grant or award of dividend equivalents on vested deferred stock units at a stated price of $0.0000 per share, and the dividend equivalents are immediately vested and follow the same terms as the underlying deferred stock units.
After this transaction, Hemsley directly holds 362,628.942 shares of common stock. He also has indirect holdings of 355.091 shares through a 401(k) plan and 692,255 shares held by trusts, which include 10,380 shares previously held directly and contributed to the trusts on January 29, 2026 in a transaction noted as exempt from reporting pursuant to Rule 16a-13.
UNITEDHEALTH GROUP INC director Charles D. Baker reported a small share award. On March 17, 2026, he acquired 14 shares of Common Stock at a price of $0.00 per share as a grant/award acquisition.
According to the footnote, these shares represent dividend equivalents paid on vested deferred stock units, which are immediately vested and subject to the same terms as the underlying deferred stock units. After this transaction, Baker directly holds 1,820 shares of UnitedHealth Group common stock.
UNITEDHEALTH GROUP INC executive Erin McSweeney, EVP & Chief People Officer, reported an acquisition of company common stock through a share-based award. She received 64.885 shares as dividend equivalents on outstanding restricted stock units at a stated price of $0.00 per share.
These dividend equivalents are subject to the same vesting terms as the underlying restricted stock units and will be forfeited if those units do not vest. Following this award, McSweeney directly holds a reported total of 15,552.923 UnitedHealth Group common shares.